Back to top

Image: Bigstock

Denali Therapeutics (DNLI) Surges: Stock Moves 5.7% Higher

Read MoreHide Full Article

Denali Therapeutics Inc. (DNLI - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 60.2% in the past one-month time frame.

The company has seen four negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Denali Therapeutics currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is negative.

A better-ranked stock in the Medical - Biomedical and Genetics industry is Abeona Therapeutics Inc. (ABEO - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot stocks we're targeting >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Abeona Therapeutics Inc. (ABEO) - free report >>

Denali Therapeutics Inc. (DNLI) - free report >>